Skip to content
Screener

Alumis Inc. ALMS Other income, net (Note 6)

Other income, net (Note 6) at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$8K+260%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$468K-127%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$98K+45.9%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$81K-325%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-$1K+50.0%
Incyte logo
IncyteINCY
$6.28M-14.1%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.54B+686%
Enterprise value$3.52B+940%
P/S421.8×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Alumis Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:16 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001847367-26-000010
(in thousands, except share and per share amounts)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Loss from operations(98,409)(101,528)
Other income (expense):
Interest income5,3492,609
Other income (expenses), net7(44)
Total other income (expense), net5,3562,565
Net loss$(93,053)$(98,963)
Other comprehensive income (loss):
Unrealized gain (loss) on marketable securities, net(655)(48)

Item 1. Financial Statements (Unaudited)

FAQ

What is Alumis Inc.'s other income, net (note 6)?
Alumis Inc. (ALMS) reported other income, net (note 6) of $7K in Q1 2026.
How has Alumis Inc.'s other income, net (note 6) changed year-over-year?
Alumis Inc.'s other income, net (note 6) increased by 115.9% year-over-year, from -$44K to $7K.
What is the long-term trend for Alumis Inc.'s other income, net (note 6)?
Over 2 years (2023 to 2025), Alumis Inc.'s other income, net (note 6) has grown at a 57.6% compound annual growth rate (CAGR), from -$68K to -$169K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about Alumis Inc.'s other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude